Jesse I. Treu, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 222 shares at $5.02 ($1K) on 2013-02-19, disclosed to the SEC on 2013-02-20.
Scheduled sale ($1k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 51 | $255 | 22.9% |
| 2 | $5.02 | 171 | $858 | 77.1% |
| Total | $5.02 avg | 222 | $1K | 100% |
| Filing → |
| OBLN | BUY | 2018-08-27 | $6.0M | — | Filing → |
| VCYT | SELL | 2018-08-02 | $10.8M | — | Filing → |
| VCYT | SELL | 2017-05-18 | $18K | — | Filing → |